An agentic platform for designing cancer immunotherapies: from automated variant interpretation to in silico therapeutic validation.
Engineer and validate hyper-lethal CRISPR guide RNAs for absolute precision gene annihilation or forced activation.
Forge flawless, high-efficiency DNA repair templates for perfect, scarless correction of genetic defects.
Engineer de novo protein weapons (e.g., nanobodies, inhibitors) with overwhelming therapeutic superiority.
Generate entire, biologically coherent genomes from scratch, authoring new blueprints for life.
Design hyper-specific genetic "on/off" switches that respond to precise cellular states.
Generate CRISPR guide RNAs with minimal off-targets and maximum on-target efficiency using Evo2's genomic understanding.
Design optimized repair templates with ultra-long homology arms for precise genome editing and therapeutic corrections.
Generate optimized protein sequences for enhanced therapeutic properties, including improved stability, binding affinity, and reduced immunogenicity.
Design tissue-specific promoters and enhancers for controlled gene expression with minimal off-target activation.
Optimize sequences for enhanced chromatin accessibility and favorable epigenetic landscapes.
Powered by Evo2 40B-parameter foundation model with 1M-token context window